Lisa Eidenschink Brodersen, PhD
Associate Professor of Pathology and Laboratory Medicine at the Children's Hospital of PhiladelphiaPerelman School of Medicine at the University of Pennsylvania
Contact Information3401 Civic Center Blvd.
Philadelphia, PA, 19104
Email: brodersenl@chop.edu
Education
BA (Chemistry and Biology), St. Olaf College , 2003
PhD (Chemistry), University of Washington , 2009
Specialty Certification
American Board of Bioanalysis High Complexity Laboratory, 2017
Postgraduate Training
Post-Doctoral Scientist, Hematologics Inc., 2009-2011
Awards and Honors
Board Certified High Complexity Laboratory Director – American Board of Bioanalysis (ABB), 2017
Best Abstract Nominee – American Society of Hematology (ASH) Annual Meeting, 2020
Memberships and Professional Organizations
European LeukemiaNet Working Group for Flow Cytometry in
Myelodysplastic Syndromes (IMDSFLOW), 2011 - Present
American Society of Hematology, 2017 - Present
Children’s Oncology Group Myeloid Disease Committee, 2017 - 2023
Fred Hutchinson Cancer Center, 2021 - 2023
Clinical Cytometry Society, 2025 - Present
Member NCCN Committee pediatric AML guidelines, 2026 - Present
Web Links
Selected Publications
FLT3 (CD135) expression in pediatric AML is associated with distinct features and worse outcomes with sorafenib therapy.
Menssen AJ, Ashango AB, Alonzo TA, Gerbing RB, Pardo L, Hsu FC, Lott LL, Dai F, Cooper TM, Pollard JA, Tarlock K, Aplenc R, Meshinchi S, Brodersen LE, Wells DA, Loken MR, Hudson CA.Blood Neoplasia. 2026 Jul 7;3(3):100268. doi: 10.1016/j.bneo.2026.100268. eCollection 2026 Aug.PMID: 42602269, Free PMC article, 2026, PMID:42602269
Multiomic Characterization of a Rare Case of Pediatric Acute Leukemia With a Novel ANGPT1:HOXA10-AS Fusion.
Newman H, Wong D, Schubert J, Wu J, Santana J, Long A, Zhou Z, Xu F, Chen J, Takeda M, Brodersen LE, Bernt KM, Luo M, Tasian SK, Li MM, Zhong Y.JCO Precis Oncol. 2026 Aug;10(9):e2600409. doi: 10.1200/PO-26-00409. Epub 2026 Sep 1.0000, Precis Oncol, 2026
AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group
Pollard JA, Alonzo TA, Gerbing RB, Kutny M, Hirsch B, Raca G, Leger K, Wilkes J, Pabari R, Wadhwa A, Graff Z, Kahwash S, Chisholm K, Chewning J, Horan J, Aplenc R, Place A, Tasian SK, Tarlock K, Menig S, Militano O, Ky B, Hudson C, Loken MR, Menssen A, Eidenschink Brodersen L, Meshinchi S, Kolb EA, Cooper TM, Journal of Clinical Oncology, 2026, PMID:42497367
Plasticity under pressure: biology and detection of lineage switch in acute leukemia
Kovach AE, Ding YY, Lamble AJ, Bernt K, Bomken S, Brodersen LE, Buldini B, Delgado Colon D, Coorens THH, Green Gladden R, Gu Z, Hu S, Jacoby E, Janssens D, Kurzer JH, Mejstrikova E, Raikar SS, Rheingold SR, Silbert SK, Tan K, Yuan CM, Wang HW, Ghorashian S, Shah NN, Davis KL, Leukemia, 2026, PMID:42362807
Diagnosis and management of AML in pediatric patients
Zwaan CM, Tasian SK, Aplenc R, Brodersen LE, Buldini B, De Moerloose B, Dworzak MN, Fogelstrand L, Gibson BES, Goemans BF, Hasle H, Hirsch BA, Kaspers GJL, Klusmann JH, Kutny MA, Lehrnbecher T, Locatelli F, Meshinchi S, Petit A, Pigazzi M, Tierens A, Kolb EA, Reinhardt D, Tomizawa D, Cooper TM, Blood, 2026
Molecular risk markers define risk of relapse in myeloid leukemia of Down syndrome beyond measurable residual disease
Berman JN, Verma A, Viola S, Alonzo TA, Wang YC, Eidenschink Brodersen L, Loken M, Beckman A, Hirsch B, Raimondi S, Chisholm KM, Ma X, Ries R, Meshinchi S, Gamis A, Schore R, Taub JW, Kolb EA, Cooper T, Hitzler J, Blood Advances 10(5): , 2026, PMID:41124669
Diagnosis and Management of AML in Pediatric Patients: Consensus Recommendations from an International Expert Panel
Zwaan CM, Tasian SK, Aplenc R, Brodersen LE, Buldini B, De Moerloose B, Dworzak MN, Fogelstrand L, Gibson BE, Goemans BF, Hasle H, Hirsch BA, Kaspers GJ, Klusmann JH, Kutny MA, Lehrnbecher T, Locatelli F, Meshinchi S, Petit A, Pigazzi M, Tierens A, Kolb EA, Reinhardt D, Tomizawa D, Cooper TM, Blood, 2025, PMID:41105890
Analysis of 3346 patients
Andrew Menssen, Jacqueline Cook, Todd Alonzo, Robert Gerbing, Maria Pardo, Fan-Chi Hsu, Loren Lott, Fangyan Dai, Amenech Ashango, Thanh Thanh Dinh, Todd Cooper, Jessica Pollard, Katherine Tarlock, Lisa Brodersen, Michael Loken, Soheil Meshinchi, Chad Hudson, American Society of Hematology, 2025
Chemotherapy selects for myeloid subclones in multiple subtypes of B-cell acute lymphoblastic leukemia
Fatemeh Alikarami, Rushabh Mehta, Changya Chen, Lisa Brodersen, David Teachey, Kai Tan, Kathrin Bernt, American Society of Hematology, 2025
A novel intercontinental external quality assessment program for flow cytometric measurable residual disease assessment in pediatric AML
Margarita Maurer-Granofszky, Flavia Battistutta, Boutheina Bouslama, Lisa Brodersen, Chad Hudson, Christel Katerkamp, Pamela Scarparo, Anastasia Soboli, Jeroen te Marvelde, Barbara Buldini, Linda Fogelstrand, David Gillis, Hélène Lapillonne, Michael Loken, Vincent van der Velden, Nils Von Neuhoff, Lucy Wheeler, Todd Cooper, Sarah Tasian, Dirk Reinhardt, Gwen Nichols, C. Zwaan, Michael Dworzak, American Society of Hematology, 2025
